CMND Stock Analysis: Buy, Sell, or Hold?
CMND - Clearmind Medicine Inc. Common Shares
$0.97
-0.01 (-1.52%)
▼
5d:
-43.14%
30d:
-41.41%
90d:
-71.06%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 10, 2026
0d
Get Alerted When CMND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CMND is down 43.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CMND is down 43.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CMND is currently trading at $0.97, which is considered oversold relative to its 30-day fair value range of $1.51 to $1.91.
Technical Outlook: Technically, CMND is showing sideways momentum. Immediate support is located at $0.92, while resistance sits at $2.10.
Market Sentiment: CMND scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CMND is showing sideways momentum. Immediate support is located at $0.92, while resistance sits at $2.10.
Market Sentiment: CMND scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.51 -
$1.91
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.51 -
$1.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$2.10
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Share & Embed Analysis
Last updated: September 12, 2026 10:10 PM ET
Data refreshes hourly during market hours. Next update: 11:10 PM
Data refreshes hourly during market hours. Next update: 11:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 50 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
